《中国银屑病诊疗指南(2023版)》解读

2023-10-11 同济大学学报发表于陕西省

在辅助检查方面,新指南推荐加强无创性影像学检查的应用;在治疗方面,新指南优化了对传统药物的治疗建议,并对生物制剂及小分子靶向药物的应用指导进行了细化补充。本文就新指南的要点进行解读。

中文标题：

发布机构：

发布日期：

2023-10-11

简要介绍：

在中华医学会皮肤性病学分会银屑病专业委员会的领导下,全国31位专家组成编写委员会在《中国银屑病诊疗指南(2018版)》的基础上,经过反复讨论和商榷,对原版指南进行补充和修订,形成了《中国银屑病诊疗指南(2023版)》。新指南对银屑病严重程度分级标准以及诊断分型标准进行了更新,并且对银屑病共病概念进行了补充完善。在辅助检查方面,新指南推荐加强无创性影像学检查的应用;在治疗方面,新指南优化了对传统药物的治疗建议,并对生物制剂及小分子靶向药物的应用指导进行了细化补充。本文就新指南的要点进行解读。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=8149e1c003383800, title=《中国银屑病诊疗指南(2023版)》解读, enTitle=, guiderFrom=同济大学学报, authorId=0, author=, summary=在辅助检查方面,新指南推荐加强无创性影像学检查的应用;在治疗方面,新指南优化了对传统药物的治疗建议,并对生物制剂及小分子靶向药物的应用指导进行了细化补充。本文就新指南的要点进行解读。, cover=https://img.medsci.cn/20221109/1668017217327_4754896.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Oct 11 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p>在中华医学会皮肤性病学分会银屑病专业委员会的领导下,全国31位专家组成编写委员会在《中国银屑病诊疗指南(2018版)》的基础上,经过反复讨论和商榷,对原版指南进行补充和修订,形成了《中国银屑病诊疗指南(2023版)》。新指南对银屑病严重程度分级标准以及诊断分型标准进行了更新,并且对银屑病共病概念进行了补充完善。在辅助检查方面,新指南推荐加强无创性影像学检查的应用;在治疗方面,新指南优化了对传统药物的治疗建议,并对生物制剂及小分子靶向药物的应用指导进行了细化补充。本文就新指南的要点进行解读。</p>, tagList=[TagDto(tagId=4418, tagName=银屑病)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=4418, articleKeyword=银屑病, articleKeywordNum=6, guiderKeywordId=4418, guiderKeyword=银屑病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7223, appHits=227, showAppHits=0, pcHits=1249, showPcHits=6995, likes=0, shares=32, comments=7, approvalStatus=1, publishedTime=Wed Oct 11 16:45:00 CST 2023, publishedTimeString=2023-10-11, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Oct 11 13:45:12 CST 2023, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 21:04:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=陕西省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《中国银屑病诊疗指南(2023版)》解读_史玉玲.pdf《中国银屑病诊疗指南(2023版)》解读_史玉玲.pdf)])

《中国银屑病诊疗指南(2023版)》解读_史玉玲.pdf《中国银屑病诊疗指南(2023版)》解读_史玉玲.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2266845, encodeId=2d31226684518, content=学习了，非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=Nininana, createdTime=Tue May 27 11:23:46 CST 2025, time=2025-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206290, encodeId=0613220629029, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb1f5338210, createdName=fy1940, createdTime=Thu May 23 20:16:33 CST 2024, time=2024-05-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2206008, encodeId=16d22206008a2, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eab8666601, createdName=ms2000001842706158, createdTime=Wed May 22 14:53:37 CST 2024, time=2024-05-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162308, encodeId=4c312162308d6, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220801/c298eeb2259c4110b14179b97aba2e82/436f77ef216745e49f4d7dbc87ea096e.jpg, createdBy=15fd6475276, createdName=坐井观天下, createdTime=Thu Oct 12 09:25:26 CST 2023, time=2023-10-12, status=1, ipAttribution=海南省)]
2025-05-27 Nininana 来自上海

学习了，非常棒

10 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=2266845, encodeId=2d31226684518, content=学习了，非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=Nininana, createdTime=Tue May 27 11:23:46 CST 2025, time=2025-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206290, encodeId=0613220629029, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb1f5338210, createdName=fy1940, createdTime=Thu May 23 20:16:33 CST 2024, time=2024-05-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2206008, encodeId=16d22206008a2, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eab8666601, createdName=ms2000001842706158, createdTime=Wed May 22 14:53:37 CST 2024, time=2024-05-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162308, encodeId=4c312162308d6, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220801/c298eeb2259c4110b14179b97aba2e82/436f77ef216745e49f4d7dbc87ea096e.jpg, createdBy=15fd6475276, createdName=坐井观天下, createdTime=Thu Oct 12 09:25:26 CST 2023, time=2023-10-12, status=1, ipAttribution=海南省)]
2024-05-23 fy1940 来自云南省

学习！

0 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=2266845, encodeId=2d31226684518, content=学习了，非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=Nininana, createdTime=Tue May 27 11:23:46 CST 2025, time=2025-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206290, encodeId=0613220629029, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb1f5338210, createdName=fy1940, createdTime=Thu May 23 20:16:33 CST 2024, time=2024-05-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2206008, encodeId=16d22206008a2, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eab8666601, createdName=ms2000001842706158, createdTime=Wed May 22 14:53:37 CST 2024, time=2024-05-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162308, encodeId=4c312162308d6, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220801/c298eeb2259c4110b14179b97aba2e82/436f77ef216745e49f4d7dbc87ea096e.jpg, createdBy=15fd6475276, createdName=坐井观天下, createdTime=Thu Oct 12 09:25:26 CST 2023, time=2023-10-12, status=1, ipAttribution=海南省)]
2024-05-22 ms2000001842706158 来自北京

积分不够

63 1 举报

展开1条回复
[GetPortalCommentsPageByObjectIdResponse(id=2266845, encodeId=2d31226684518, content=学习了，非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=Nininana, createdTime=Tue May 27 11:23:46 CST 2025, time=2025-05-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206290, encodeId=0613220629029, content=学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb1f5338210, createdName=fy1940, createdTime=Thu May 23 20:16:33 CST 2024, time=2024-05-23, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2206008, encodeId=16d22206008a2, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eab8666601, createdName=ms2000001842706158, createdTime=Wed May 22 14:53:37 CST 2024, time=2024-05-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2162308, encodeId=4c312162308d6, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220801/c298eeb2259c4110b14179b97aba2e82/436f77ef216745e49f4d7dbc87ea096e.jpg, createdBy=15fd6475276, createdName=坐井观天下, createdTime=Thu Oct 12 09:25:26 CST 2023, time=2023-10-12, status=1, ipAttribution=海南省)]
2023-10-12 坐井观天下来自海南省

积分不够

129 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

皮肤性病指南

《中国银屑病诊疗指南(2023版)》解读

相关指南

拓展阅读

科室

工具

服务